Dallas AI co-founder Babar Bhatti (left) and global supply chain leader Masood Khan with their new "Beginner to Executive Prompting Guide," launched at SMU's Dallas AI Summer Program. [Courtesy photos]
Most people are getting AI all wrong—asking random questions and getting mediocre results, say Babar Bhatti and Masood Khan. Their new guide shows how to prompt like a pro and turn AI into your strategic team.
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
Sunday was national AI Appreciation Day, so to mark it, the Dallas Regional Chamber did a Q&A with Charania and Babar Bhatti, co-founder and EVP of DallasAI, a nonprofit forum to accelerate learning and adoption of artificial intelligence.
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....